These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14688633)

  • 1. Troubleshooting pacemakers and implantable cardioverter-defibrillators.
    Scher DL
    Curr Opin Cardiol; 2004 Jan; 19(1):36-46. PubMed ID: 14688633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stored electrograms in pacemakers and ICDs from St. Jude Medical].
    Israel CW
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):53-70. PubMed ID: 20309672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stored electrograms in pacemakers and ICD systems from the Sorin Group].
    Mletzko RU; Ocklenburg R; Prizelius L
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):41-52. PubMed ID: 20198377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of stored electrograms for implantable cardioverter-defibrillator (ICD) troubleshooting and understanding of mechanisms for ventricular tachyarrhythmias.
    Auricchio A; Hartung W; Geller C; Klein H
    Am J Cardiol; 1996 Sep; 78(5A):33-41. PubMed ID: 8820834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pacemaker stored electrograms: teaching us what is really going on in our patients.
    Nowak B
    Pacing Clin Electrophysiol; 2002 May; 25(5):838-49. PubMed ID: 12049378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmias in Patients with Implantable Devices.
    Sciarra L; Nesti M; Palamà Z; Marazzato J; Bagliani G; Leonelli FM; De Ponti R
    Card Electrophysiol Clin; 2019 Jun; 11(2):363-373. PubMed ID: 31084856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.
    Saeed M; Jin A; Pontone G; Higgins S; Gold M; Harari D; Nunley S; Link MS; Homoud MK; Estes NA; Wang PJ;
    Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):219-26. PubMed ID: 14510657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker].
    Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R
    G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stored electrograms in pacemakers and ICDs from Medtronic].
    Kloppe A; Kloppe C; Lemke B; Zarse M
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):26-40. PubMed ID: 20224933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stored electrograms in pacemakers and ICDs from Boston Scientific].
    Schaumann A; Israel CW
    Herzschrittmacherther Elektrophysiol; 2010 Mar; 21(1):18-25. PubMed ID: 20229193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Troubleshooting in Patients with Implanted Pacemaker and ICD].
    Meyer Zu Vilsendorf D; Hansky B; Baumann P; Stellbrink C
    Dtsch Med Wochenschr; 2018 Nov; 143(22):1608-1616. PubMed ID: 30376684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stored electrograms on management in the paced patient.
    Huikuri H
    Am J Cardiol; 2000 Nov; 86(9A):101K-103K. PubMed ID: 11084107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy.
    Brambatti M; Mathew R; Strang B; Dean J; Goyal A; Hayward JE; Long L; DeMeis P; Smoke M; Connolly SJ; Morillo CA; Amit G; Capucci A; Healey JS
    Heart Rhythm; 2015 Oct; 12(10):2148-54. PubMed ID: 26049049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter-defibrillators.
    Grubman EM; Pavri BB; Shipman T; Britton N; Kocovic DZ
    J Am Coll Cardiol; 1998 Oct; 32(4):1056-62. PubMed ID: 9768732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies.
    Res JC; Theuns DA; Jordaens L
    Clin Res Cardiol; 2006; 95 Suppl 3():III17-21. PubMed ID: 16598599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.